WO2012112458A3 - Compositions and methods for increasing reprogramming efficiency - Google Patents
Compositions and methods for increasing reprogramming efficiency Download PDFInfo
- Publication number
- WO2012112458A3 WO2012112458A3 PCT/US2012/024902 US2012024902W WO2012112458A3 WO 2012112458 A3 WO2012112458 A3 WO 2012112458A3 US 2012024902 W US2012024902 W US 2012024902W WO 2012112458 A3 WO2012112458 A3 WO 2012112458A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- compositions
- reprogramming efficiency
- pluripotent cell
- efficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/603—Oct-3/4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/604—Klf-4
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/724—Glycosyltransferases (EC 2.4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Developmental Biology & Embryology (AREA)
- Transplantation (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to methods for enhancing the efficiency of reprogramming a non-pluripotent cell to a pluripotent cell, comprising expressing in the cell an effective amount of pluripotency factors and an effective amount of PARP-1 or an equivalent thereof, thereby enhancing the efficiency of reprogramming the non-pluripotent cell to the pluripotent cell.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161442554P | 2011-02-14 | 2011-02-14 | |
| US61/442,554 | 2011-02-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012112458A2 WO2012112458A2 (en) | 2012-08-23 |
| WO2012112458A3 true WO2012112458A3 (en) | 2012-11-15 |
Family
ID=46673107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2012/024902 Ceased WO2012112458A2 (en) | 2011-02-14 | 2012-02-13 | Compositions and methods for increasing reprogramming efficiency |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012112458A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2873727B1 (en) * | 2012-07-12 | 2019-11-06 | Kyoto Prefectural Public University Corporation | Brown fat cells and method for preparing same |
| CN104419683A (en) * | 2013-09-10 | 2015-03-18 | 中国科学院生物物理研究所 | Method for preparing autologous induced pluripotent stem cells of patient with Fanconi anemia and application of method |
| CA2924735C (en) * | 2013-09-20 | 2023-02-28 | Lonza Ltd | Methods for nuclear reprogramming of cells |
| RU2711942C2 (en) * | 2014-03-19 | 2020-01-23 | Виселл Терапеутикс, Инк. | Methods relating to pluripotent cells |
| CN108070563A (en) * | 2016-11-17 | 2018-05-25 | 中国科学院大连化学物理研究所 | A kind of preparation method of inductive pluripotent stem cells |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090068742A1 (en) * | 2005-12-13 | 2009-03-12 | Shinya Yamanaka | Nuclear Reprogramming Factor |
| US20090304646A1 (en) * | 2007-06-15 | 2009-12-10 | Kazuhiro Sakurada | Multipotent/Pluripotent Cells and Methods |
-
2012
- 2012-02-13 WO PCT/US2012/024902 patent/WO2012112458A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090068742A1 (en) * | 2005-12-13 | 2009-03-12 | Shinya Yamanaka | Nuclear Reprogramming Factor |
| US20090304646A1 (en) * | 2007-06-15 | 2009-12-10 | Kazuhiro Sakurada | Multipotent/Pluripotent Cells and Methods |
Non-Patent Citations (2)
| Title |
|---|
| FURONG GAO ET AL.: "PARP1 poly(ADP-ribosyl)ates Sox2 to Control Sox2 Protein Levels and FGF4 Expression during Embryonic Stem Cell Differentiation", J BIOL CHEM., vol. 284, no. 33, 16 June 2009 (2009-06-16), pages 22263 - 22273 * |
| VIMAL SELVARAJ ET AL.: "PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis", J BIOL CHEM., vol. 284, no. 38, 18 September 2009 (2009-09-18), pages 26070 - 26084 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012112458A2 (en) | 2012-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277891B1 (en) | Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces | |
| EP3019596A4 (en) | Compositions and methods for reprograming non- pluripotent cells into pluripotent stem cells | |
| IL252063B (en) | Dna-pk inhibitors, compositions comprising same and uses thereof | |
| EP4438734A3 (en) | Reprogramming of cells to a new fate | |
| EP2904103B8 (en) | Method for preparing induced pluripotent stem cells and its applications | |
| SI2785359T1 (en) | Mesenchymal stromal cells and uses related thereto | |
| WO2014012078A3 (en) | Selective wetting and transport surfaces | |
| EP2549864A4 (en) | Methods for increasing tolerance to abiotic stress in plants | |
| ZA201403109B (en) | Modulating beta-damascenone in plants | |
| WO2011159770A3 (en) | Methods and compositions for promoting hair growth | |
| GB2503131B (en) | Systems, compositions and methods for transplantation | |
| GB2489187B (en) | Compositions, methods and related uses for cleaving modified DNA | |
| WO2012096461A3 (en) | Composition for suspension culturing of stem cells | |
| IL227529A0 (en) | Compositions and methods for cell transplantation | |
| EP2880050A4 (en) | Novel enzymes, enzyme components and uses thereof | |
| SG11201400480SA (en) | Polymer and composition including same, and adhesive composition | |
| WO2011119986A3 (en) | Methods for culturing and analyzing cells | |
| EP2794797A4 (en) | An ultraviolet-curable and moisture-curable adhesive composition | |
| ZA201208135B (en) | Systems, methods and composition relating to combustible biomaterials | |
| HK1254740A1 (en) | Methods for differentiating and purifying pancreatic endocrine cells | |
| WO2012112458A3 (en) | Compositions and methods for increasing reprogramming efficiency | |
| PL2776174T3 (en) | Valve, in particular glue valve | |
| EP2294182A4 (en) | Multipotent stem cell cultures | |
| IL218955A0 (en) | Genes, methods, and compositions related to neurogenesis and its modulation | |
| WO2012044979A3 (en) | Manipulation of stem cell function by p53 isoforms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12747293 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12747293 Country of ref document: EP Kind code of ref document: A2 |